SYNTHESE VON DIPEPTIDANALOGA

European patent · EP1682506 · Deleted

Register entry

Publication number
EP1682506
Application number
EP04818314
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Oct 27, 2004
Published
Jul 26, 2006
Granted
Dec 30, 2009
Deleted
Oct 31, 2010
Reason
Annual fee unpaid
IPC classes
C07D 211/66 (2006.01)
Priority
US 515848 P 30.10.2003
PCT application
PCT/US2004/035833 27.10.2004
PCT publication
WO2005/044799 19.05.2005
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. May 18, 2011

    Deleted, fee unpaid

    Published in Swissreg on 18.05.2011

  2. Dec 30, 2009

    Granted

    Published in Swissreg on 30.12.2009

Parties

Inventor

BUSACCA, C.A., Boehringer Ingelheim Pharmaceut.

Ridgefield, CT 06877-0368, US

HADDAD, N., Boehringer Ingelheim Pharmaceuticals

Ridgefield, CT 06877-0368, US

KAPADIA, S.R., Boehringer Ingelheim Pharmaceutic.

Ridgefield, CT 06877-0368, US

SMITH KEENAN, L., Boehringer Ingelheim Pharmac.

Ridgefield, CT 06877-0368, US

LORENZ, J.C., Boehringer Ingelheim Pharmaceuticals

Ridgefield, CT 06877-0368, US

SENANAYAKE, C.H., Boehringer Ingelheim Pharmaceut.

Ridgefield, CT 06877-0368, US

WEI, X., Boehringer Ingelheim Pharmaceuticals, Inc

Ridgefield, CT 06877-0368, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.